Bangkok - 02/16/2021 — Supreme Pharmatech Co., Ltd. announced, that they have reached an agreement with world renowned scientist, Professor M.R.Mozafari, to join hands in development and production of a new generation of food supplement products based on liposomal technology.
Mrs. Milint Winthasiri, Chief Executive Officer of Supreme Pharmatech Co., Ltd., said that the company is delighted to join forces with Professor M.R. Mozafari, who will lead the Research and Development Department at Supreme Nanobiotics, which is one of the companies of Supreme Group.
Supreme Pharmatech Co., Ltd. is becoming first company in South-East Asia to invest in liposomal nanotechnology. Currently there are no local supplement manufacturers invested in liposomal technology due to the complexity of the process and high cost of investment.
In 2021 Supreme Pharmatech will focus on the development of liposomal ingredients, which are in the highest demand worldwide. Some of ingredients are — liposomal vitamins C and D3, liposomal calcium and magnesium, liposomal coenzyme Q10 and astaxanthin, as well as liposomal bioactive ingredients – apigenin, curcumin, quercetin, kaempherol, hesperidin, silymarin, gingerol, berberine, resveratrol and many more.
A liposomal delivery system has many advantages over regular oral ingestion. The lipid components of liposomes are natural phospholipids, which are impervious to the various digestive enzymes, such as acids and bile salts. Moreover, the liposomes are entering the blood stream through the lymph system, bypassing the liver.
Prof. M.R. Mozafari is a world class expert in the fields of encapsulation & controlled release of bioactive agents, nano-biotechnology, drug delivery & targeting. He has authored more than 200 publications, including 8 patents and 5 books, which are among the first books in the field of pharmaceutical nanotechnology and nanobiotechnology.
His book “Nanoliposomes: from fundamentals to recent developments” is the very first book on nanoliposomes ever written. He has developed and patented a new method of industrial-scale manufacturing of liposomes, named for his research as the “Mozafari Method”.
In 2021 Supreme Pharmatech plans to open 6-7 more new branches abroad. All export sales will be based on liposomal or semi-liposomal poly-formulations with a wide application. Supreme Pharmatech also has plans to adapt exported formulations to the local market and cooperate with local buyers of food supplement products on an OEM basis.
Supreme Pharmatech and Professor M.R.Mozafari are putting maximum effort to bring significant changes to the world’s industry of food supplements and lift-up the image of Thailand as one of the world’s leading countries in nano-technology.
Media Contacts:Company Name: Supreme Pharmatech Co., Ltd